The application of integral medicine in the treatment of myalgic encephalomyelitis/ chronic fatigue syndrome

Journal of Integral Theory and Practice

Volumn 6, Issue 4, 2011, Pages 25-40

  Howard, Alex ^a   Arroll, Megan ^a  

^a The Optimum Health Clinic   (United Kingdom)

Author keywords

Chronic fatigue syndrome; Medicine; Myalgic encephalomyelitis; Quadrants; Treatment

Indexed keywords

EID: 84855262087     PISSN: 19445083     EISSN: 19445091     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Acheson, E.D. (1959). The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. American Journal of Medicine, 26, 569-595.
2. Ader, R. (2002). Psychoneuroimmunology. Current Directions in Psychological Science, 10, 94-98.
3. Ader, R. & Cohen, N. (1975). Behaviorally conditioned immunosuppression. Psychosomatic Medicine, 37, 333-340.
4. Adler, R. H. (2004). Chronic fatigue syndrome (CFS): A review and a proposition of a bio-psycho-social model of chronic fatigue syndrome. Swiss Medical Weekly, 134, 268-276.
5. Afari, N. & Buchwald, D. (2003). Chronic fatigue syndrome: A review. American Journal of Psychiatry, 160, 221-236.
6. Arroll, M.A., Attree, E.A., & Dancey, C.P. (2010). A qualitative investigation of everyday worries in individuals with myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS). Poster presented at the European Health Psychology Society: Cluj-Napoca, Romania.
7. Arroll, M.A. & Senior, V. (2008). Individuals' experience of chronic fatigue syndrome/myalgic encephalomyelitis: An interpretative phenomenological analysis. Psychology and Health, 23, 443-458.
8. Asbring, P. & Naervaenen, A.L. (2002). Women's experiences of stigma in relation to chronic fatigue syndrome and fibromyalgia. Qualitative Health Research, 12, 148-160.
9. Beard, G. (1869). Neurasthenia or nervous exhaustion. Boston Medical and Surgical Journal, 217-221.
10. Bond, J.O. (1956). A new clinical entity? Lancet, 256.
11. Carruthers, B.M., Jain, A.K., de Meirleir, K.L., Peterson, D.L., Klimas, N.G., Lerner, A.M., et al. (2003). Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. Journal of Chronic Fatigue Syndrome, 11, 7-115.
12. Chapenko, S., Krumina, A., Kozireva, S., Nora, Z., Sultanova, A., Viksna, L., et al. (2006). Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome. Journal of Clinical Virology, 37, S47-S51.
13. Eriksen, H. R. & Ursin, H. (2004). Subjective health complaints, sensitization, and sustained cognitive activation (stress). Journal of Psychosomatic Research, 56, 445-448.
14. Fernandez-Sola, J., Padierna, L. M., Xarau, N. S., & Mas, P. M. (2005). Chronic fatigue syndrome (CFS) and multiple chemical hypersensitivity (MCS) after insecticide exposition. Medicina clínica Facultad de Medicina de Barcelona, 124, 451-453.
15. Fiedler, N., Lange, G., Tiersky, L., Deluca, J., Policastro, T., Kelly-McNeil, K., et al. (2000). Stressors, personality traits, and coping of Gulf War veterans with chronic fatigue. Journal of Psychosomatic Research, 48, 525-535.
16. Fries, E., Hesse, J., Hellhammer, J., & Hellhammer, D.H. (2005). A new view of hypocortisolism. Psychoneuroendocrinology, 30, 1010-1016.
17. Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M.C., Dobbins, J.G., & Komaroff, A. (1994). The chronic fatigue syndrome: A comprehensive approach to its definition and study. Annals of Internal Medicine, 121, 953-959.
18. Groom, H.C., Boucherit, V.C., Makinson, K., Randal, E., Baptista, S., et al. (2010). Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology, 7, Epub access. Retrieved March 20, 2011, from http://www.retrovirology.com/content/7/1/10.
19. Hamilton, W.T., Gallagher, A.M., Thomas, J.M., & White, P.D. (2005). The prognosis of different fatigue diagnostic labels: A longitudinal survey. Family Practice, 22, 383-388.
20. Hatcher, S. & House, A. (2003). Life events, difficulties and dilemmas in the onset of chronic fatigue syndrome: A case-control study. Psychological Medicine, 33, 1185-1192.
21. Hickie, I., Davenport, T., Wakefield, D., Vollmer-Conna, U., Cameron, B., Vernon, S.D., et al. (2006). Post-infective and chronic fatigue syndromes precipitated by viral pathogens: Prospective cohort study. British Medical Journal, 333, 575-582.
22. Holmes, G.P., Kaplan, J. E., Gantz, N.M., Komaroff, A.L., Schonberger, L.B., Straus, S.E., et al. (1988). Chronic fatigue syndrome: A working case definition. Annals of Internal Medicine, 108, 387-389.
23. Hong, P., Li, J., & Li, Y. (2010). Failure to detect xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virology Journal, 13, 224.
24. Jason, L.A., Fennell, P.A., & Taylor, R.R. (2003). Handbook of chronic fatigue syndrome. Hoboken, NJ: Wiley.
25. Johnson, S.K. (1998). The biopsychosocial model and chronic fatigue syndrome. American Psychologist, 53, 1080-1081.
26. Johnson, S.K., Deluca, J., & Natelson, B.H. (1999). Chronic fatigue syndrome: Reviewing the research findings. Annals of Behavioral Medicine, 21, 258-271.
27. Kaplan, H.B. (1991). Social psychology of the immune system: A conceptual framework and review of the literature. Social Science and Medicine, 33, 909-923.
28. Kiecolt-Glaser, J. K. & Glaser, R. (1989). Psychoneuroimmunology: Past, present and future. Health Psychology, 8, 677-682.
29. Kogelnik, A.M., Loomis, K., Hoegh-Petersen, M., Rosso, F., Hischier, C., & Montoya, J. G. (2006). Use of valganciclovir in patients with evevated antibody titers against human herpesvirus-6 (HHV-6) and Epstein-Barr virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. Journal of Clinical Virology, 37, S33-S38.
30. Lewis, S., Cooper, C. L., & Bennett, D. (1994). Psychosocial factors and chronic fatigue syndrome. Psychological Medicine, 24, 661-671.
31. Lombardi, V.C., Ruscetti, F.W., Gupta, J.D., Pfost, M.A., Hagen, K.S., et al. (2009). Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science, 326, 585-589.
32. Lord Kirkwood. (2011). House of Lords motion to annul Work Capability Assessment regulations. House of Lords Debate. Retrieved April 24, 2011, from http://www.meassociation.org.uk/?p=5180.
33. McEcedy, C.P., & Beard, A.W. (1970). Royal Free epidemic of 1955; A reconsideration. British Medical Journal, 1, 7-11.
34. ME Association. (2009). Concern at closure of ME clinic in Northern Ireland. Retrieved April 4, 2011, from http://www.meassociation.org.uk/?p=693.
35. ME Association. (2010). "Cuts doom plans for ME clinics"-Manchester Evening News. Retrieved April 3, 2011, from http://www.meassociation.org.uk/?p=862.
36. Nicolson, G.L., Berns, P., Nasralla, M.Y., Haier, J., Nicolson, N.L., & Nass, M. (2003). Gulf War illnesses: Chemical, biological and radiological exposures resulting in chronic fatiguing illnesses can be identified and treated. Journal of Chronic Fatigue Syndrome, 11, 2003, 135-2003, 154.
37. Ramsey, A.M. (1976). Benign myalgic encephalomyelitis or epidemic neuromyasthenia. GP Update, 12, 539-542.
38. Reid, S., Chalder, T., Cleare, A., Hotopf, M., & Wessely, S. (2000). Extracts from "Clinical Evidence": Chronic fatigue syndrome. British Medical Journal, 320, 292-296.
39. Schlitz, M., Amorok, T., & Micozzi, M. S. (2004). Consciousness and healing: Integral approaches to mind-body medicine. Churchill: Livingstone.
40. Schweitzer, R., Kelly, B., Foran, A., & Terry, D. (1995). Quality of life in chronic fatigue syndrome. Social Science and Medicine, 41, 1367-1372.
41. Spector, N.H., & Arora, P.K. (1993). Science, history and psychoneuroimmunology. The Quarterly Review of Biology, 68(2), 223-237.
42. Sundbom, E., Henningsson, M., Holm, U., Soederbergh, S., & Evengard, B. (2002). Possible influence of defenses and negative life events on patients with chronic fatigue syndrome: A pilot study. Psychological Reports, 91, 963-978.
43. Taylor, R.R., & Jason, L.A. (2002). Chronic fatigue, abuse-related traumatization, and psychiatric disorders in a community-based sample. Social Science and Medicine, 55, 247-256.
44. Taylor, R.R., & Kielhofner, G.W. (2005). Work-related impairment and employment-focused rehabilitation options for individuals with chronic fatigue syndrome: A review. Journal of Mental Health (UK), 14, 253-267.
45. Ursin, H., & Eriksen, H.R. (2004). The cognitive activation theory of stress. Psychoneuroendocrinology, 29, 567-592.
46. Van Den Eede, F., Moorkens, G., Van Houdenhove, B., Cosyns, P., & Claes, S. J. (2007). Hypothalamic-pituitary-adrenal axis functioning in chronic fatigue syndrome. Neuropsychobiology, 55, 112-120.
47. Van Houdenhove, B., Neerinckx, E., Lysens, R., Vertommen, H., Van Houdenhove, L., Onghena, P., et al. (2001). Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: A controlled study on prevalence and characteristics. Psychosomatics: Journal of Consultation Liasion Psychiatry, 42, 21-28.
48. Van Houdenhove, B., Onghena, P., Neerinckx, E., & Hellin, J. (1995). Does high "action-proneness" make people more vulnerable to chronic fatigue syndrome? A controlled psychometric study. Journal of Psychosomatic Research, 39, 633-640.
49. Van Houdenhove, B., Van Den Eede, F., & Luyten, P. (2009). Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a "crash" in the stress system? Medical Hypotheses, 72, 701-705.
50. Wilber, K. (1995). Sex, ecology, spirituality: The spirit of evolution. Boston, MA: Shambhala.